Characteristics Associated With Spontaneous <i>Helicobacter pylori</i> Clearance After Subtotal Gastrectomy in Patients With Gastric Cancer

So Young Byun; Hee Sung Kim; Ji Yong Ahn; Byung Sik Kim; Hee Kyong Na; Jeong Hoon Lee; Kee Wook Jung; Do Hoon Kim; Kee Don Choi; Ho June Song; Gin Hyug Lee; Hwoon-Yong Jung

doi:10.7704/kjhugr.2025.0029

Korean J Helicobacter Up Gastrointest Res > Volume 25(3); 2025 > Article

Byun, Kim, Ahn, Kim, Na, Lee, Jung, Kim, Choi, Song, Lee, and Jung: Characteristics Associated With Spontaneous Helicobacter pylori Clearance After Subtotal Gastrectomy in Patients With Gastric Cancer

Original Article

The Korean Journal of Helicobacter and Upper Gastrointestinal Research 2025;25(3):268-275.

Published online: September 1, 2025

DOI: https://doi.org/10.7704/kjhugr.2025.0029

Characteristics Associated With Spontaneous Helicobacter pylori Clearance After Subtotal Gastrectomy in Patients With Gastric Cancer

So Young Byun^1,^*

, Hee Sung Kim^2,^*

, Ji Yong Ahn¹

, Byung Sik Kim²

, Hee Kyong Na¹

, Jeong Hoon Lee¹

, Kee Wook Jung¹

, Do Hoon Kim¹

, Kee Don Choi¹

, Ho June Song¹

, Gin Hyug Lee¹

, Hwoon-Yong Jung¹

¹Department of Gastroenterology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea

²Department of Gastric Surgery, Gangnam CHA Medical Center, Seoul, Korea

Corresponding author Ji Yong Ahn, MD, PhD Department of Gastroenterology, Asan Medical Center, University of Ulsan College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul 05505, Korea E-mail: ji110@hanmail.net

*These authors contributed equally to this work.

Received April 25, 2025; Revised May 15, 2025; Accepted May 26, 2025;

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Objectives

Helicobacter pylori eradication treatment typically occurs after gastrectomy; however, the specific criteria for eradication treatment have not been reported. This study aimed to evaluate the rates and locations of spontaneous clearance, as well as the accompanying histological changes.

Methods

Patients with H. pylori-positive status at the time of gastric cancer diagnosis and who underwent subtotal gastrectomy at a tertiary care center in Seoul (South Korea) were prospectively enrolled in this study. H. pylori infection status and histological features (presence of mononuclear cells, neutrophils, atrophy, and intestinal metaplasia) were evaluated pre- and postoperatively at different locations in the stomach.

Results

Sixteen patients with H. pylori-positive gastric cancer underwent subtotal gastrectomy. Of these, 13 (81.3%) showed spontaneous clearance at least once during the follow-up. Half of the patients (8, 50.0%) had cleared their infections within 6 months after surgery. Histological factors, such as neutrophil and mononuclear cell counts, atrophy, and intestinal metaplasia, did not differ according to H. pylori clearance status. The spontaneous clearance rates of H. pylori were 69.2% in the cardia, 46.1% in the fundus, 38.4% in the lesser curvature of the mid-body, and 41.6% in the greater curvature of the mid-body; the differences in clearance rates were not significant (p=0.149).

Conclusions

The rate of spontaneous H. pylori clearance was high in patients with gastric cancer who underwent subtotal gastrectomy. Postoperative H. pylori status should be re-evaluated to confirm the presence of infection prior to considering eradicating therapy.

Key words: Helicobacter pylori; Gastric cancer; Gastrectomy; Spontaneous remission; Histology

INTRODUCTION

Helicobacter pylori infection is closely associated with gastric cancer development [1], which remains a major cause of death, especially in East Asian countries [2-4]. Epidemiological data from Asia show that H. pylori-positive individuals have at least twice the risk of developing stomach cancer as do those with negative results [5,6]. Infections with these bacteria often cause chronic gastritis, which can lead to precancerous changes such as atrophic gastritis and intestinal metaplasia [7,8]. The eradication of H. pylori can alleviate atrophic gastritis and intestinal metaplasia in the general population [9,10]. Consequently, most guidelines recommend screening for and eradicating these infections in high-risk patients to reduce the incidence of gastric cancer [11-14].

However, clear guidelines have not been established for H. pylori eradication following gastric cancer surgery as the postoperative gastric physiology may differ from that of the intact stomach [15]. Although the growth of these bacteria can be suppressed by bile reflux after surgery, there is a view that the bacteria can proliferate due to changes in acid secretion [16,17], making the prediction of post-gastrectomy infection status difficult.

In this study, we investigated the effect of gastric cancer surgery on H. pylori status and the accompanying histological changes. We also analyzed the differences in H. pylori infection status according to the position of the remnant stomach to determine if there was an association with gastric acid levels.

METHODS

Patients

Between March 2016 and January 2018, 93 patients underwent gastric cancer surgery at a tertiary care center in Seoul, Korea, at the time of their cancer diagnosis. These patients, eligible to participate in this study, tested to determine their H. pylori status. Among them, 16 were diagnosed with H. pylori infection and underwent distal gastrectomy; these patients were prospectively enrolled in this study. Of those ineligible to participate, some were excluded due to undergoing total or near-total gastrectomy, undergoing pre-operative endoscopic submucosal dissection, not returning for follow-up evaluations receiving postoperative chemotherapy, and undergoing prior H. pylori eradication therapy (Fig. 1). This study was approved by the Institutional Review Board of the Asan Medical Center, and written informed consent was obtained from all participants (IRB number: 2015-0823).

Evaluation of H. pylori infection

Patient H. pylori status was evaluated using the rapid urease test (RUT) and histopathological diagnosis of biopsy specimens; the presence of H. pylori in a biopsy specimen was confirmed using Wright-Giemsa staining. The RUT was considered positive when a color change from yellow to pink or red was observed within 24 hours using a urease reaction kit (CKD Hp kit^TM; ChongKunDang BiO).

Ten biopsy specimens for Sydney scoring and H. pylori diagnosis were obtained during preoperative endoscopic examinations, with two specimens taken from each of five sites (antrum, cardia, fundus, and lesser and greater curvatures of the mid-body of the stomach) using standard-sized biopsy forceps. Additional preoperative biopsy specimens for RUT were obtained from the antrum and greater curvature of the mid-body. Biopsies were performed preoperatively and 6 and 12 months after surgery. Postoperatively, 10 biopsy specimens for Sydney scoring and H. pylori diagnosis were obtained from the anastomosis site, cardia, fundus, and lesser and greater curvatures of mid-body of the stomach (two samples per site) using standard-sized biopsy forceps during the endoscopic examination. If either the RUT or the histology of the biopsy specimen was positive, the preoperative H. pylori status was considered positive. Postoperatively, the presence of H. pylori was evaluated using only biopsy specimens.

Histology

The histological features of the gastric mucosa were examined by an experienced gastrointestinal pathologist using hematoxylin-eosin and Wright-Giemsa staining. Histological markers, including numbers of neutrophils and mononuclear cells, atrophy, and intestinal metaplasia, were assessed and scored from 0 to 3 based on the updated Sydney scoring system (0=none, 1=mild, 2=moderate, and 3=severe) [18].

Definition

In this study, non-clearance was defined as H. pylori identified at any postoperative biopsy site; if bacteria were not found at any of the postoperative sites without eradication treatment, spontaneous clearance was assumed. These definitions were based on pathological evaluations.

Statistical analysis

All statistical analyses were performed using SPSS software (version 20.0; IBM Corp.). Baseline characteristics were compared using the Mann–Whitney U-test and Fisher’s exact test. Differences in histological features between individuals with a persistently positive H. pylori status and those demonstrating spontaneous clearance were calculated using the Mann–Whitney U-test. Wilcoxon’s signed-rank test was used to compare the baseline and follow-up histological findings within each group. Statistical significance was set at p<0.05.

RESULTS

Baseline characteristics

A summary of the baseline postoperative H. pylori status of the enrolled patients is shown in Table 1. The mean ages of patients with persistent H. pylori infections (non-clearance group) and those exhibiting spontaneous resolution of their infections (spontaneous clearance group) were 48.7 years and 58.4 years, respectively. Both groups predominantly included men. The non-clearance group had high percentages of individuals who were current smokers and drinkers (66.7% and 100%, respectively). All enrolled patients underwent subtotal gastrectomy involving Billroth I (B-I) reconstruction. The baseline characteristics were not significantly different between the two groups (Table 1).

Spontaneous clearance rates depending on postoperative periods

Preoperatively, all 16 patients had positive RUT results, and the histological results determined using Giemsa staining showed 81.3% (13/16) with bacteria present at the cardia, fundus, greater curvature of mid body, and antrum; 75.0% (12/16) demonstrated bacteria at the lesser curvature of mid-body. Of the 16 patients, 13 (81.3%) showed spontaneous clearance at least once during the follow-up period, with half (eight patients, 50.0%) clearing their infection within six postoperative months (Table 2).

Histological changes during follow-up

Tables 3-6 show the changes in histological factors, including numbers of neutrophils and mononuclear cells, atrophy, and intestinal metaplasia, at different stomach locations. The postoperative neutrophil and mononuclear cell counts decreased over time, albeit without showing any statistical significance between the non-clearance and spontaneous clearance groups.

In the spontaneous clearance group, the neutrophil counts in the cardia were significantly decreased (p=0.021) at 12 months postoperatively; in the lesser curvatures of the mid-bodies, the counts were significantly decreased at 6 months postoperatively (p=0.038) (Table 3). Additionally, the mononuclear cell counts were significantly decreased in the cardia and in the lesser curvatures of the mid-body at 6 and 12 months after surgery (cardia p=0.020 and 0.014, respectively; lesser curvatures of the mid-body p=0.030 and 0.016, respectively) (Table 4).

In both groups, postoperative atrophy and intestinal metaplasia tended to decrease relative to the baseline. In the spontaneous clearance group, there were significant decreases in atrophy and intestinal metaplasia by postoperative month 12 in the lesser curvatures of the mid-bodies (p=0.033 and 0.026, respectively) (Tables 5 and 6). None of the other histological factors showed significant differences between the two groups.

Spontaneous clearance rate according to stomach anatomy

The spontaneous clearance rates of H. pylori were 69.2% in the cardia, 46.1% in the fundus, 38.4% in the greater curvature of the mid-body, and 41.6% in the lesser curvature of the mid-body; the clearance rates did not differ significantly according to location (p=0.149) (Table 7).

DISCUSSION

In this prospective, single-center study, we evaluated the spontaneous eradication of H. pylori in patients 6 and 12 months after undergoing subtotal gastrectomies. The spontaneous clearance rate was high (81.3%, 13/16 patients). Notably, eight patients (50.0%) spontaneously cleared their infections within 6 months of surgery. After surgery, histological factors, specifically neutrophil and mononuclear cell counts, decreased relative to preoperative levels. The spontaneous clearance group showed significant reductions in neutrophil and mononuclear cell counts in the cardia and lesser curvature of the mid body by 12 months post-operatively.

Although the changes in H. pylori status after subtotal gastrectomy are not yet fully understood, several studies have shown spontaneous clearance of H. pylori after subtotal gastrectomies for peptic ulcers or early gastric cancer. In one study, 60 of 140 (42.9%) postoperative patients showed spontaneous clearance of these bacteria at least once during follow-up [19]. In another study, the rate of H. pylori spontaneous clearance after partial gastrectomy was 43% (13/30) [20]. Although previous studies have shown spontaneous clearance rates in the range of 40%, our study showed a higher rate (81.3%). In our study, we specifically analyzed patients who underwent B-I reconstructions. Considering that bile reflux is less commonly associated with patients undergoing B-I than those undergoing B-II reconstructions, factors other than bile reflux are believed to contribute to spontaneous clearance [21,22]. Additionally, directly comparing our study with other studies may be difficult because other studies targeted patients undergoing gastrectomies due to peptic ulcers [20].

Following a gastrectomy, the loss of the pyloric ring in the remnant stomach increases bile reflux, which worsens atrophy and intestinal metaplasia [23]. H. pylori is also known to contribute to residual-stomach gastritis after gastrectomy [24]. Some researchers believe that bile reflux is the main contributing factor, whereas others believe that bile reflux and H. pylori are interrelated contributors [25,26]. In our study, atrophy and intestinal metaplasia decreased after surgery; however, these differences were not statistically significant. Only the spontaneous clearance group showed significant improvements in atrophy and intestinal metaplasia in the lesser curvature of mid-body by 12 postoperative months. The tendency of atrophy and intestinal metaplasia to improve despite increased bile reflux during the postoperative period suggests that bile reflux is not the only factor affecting atrophy and intestinal metaplasia. In addition, significant improvements in atrophy and intestinal metaplasia in the lesser curvature of the mid-body were seen in the spontaneous clearance group, suggesting that H. pylori may also affect atrophy and intestinal metaplasia.

Neutrophils and mononuclear cells are associated with chronic inflammation of the digestive tract [27]. Histological evaluations, using the updated Sydney system revealed, that inflammatory cell infiltration increased in the presence of gastritis [28]. Gastritis caused by H. pylori infection and chronic inflammation are closely related [29]. Although some studies suggest that bile reflux and H. pylori exacerbate remnant gastritis and increase histological inflammation, others have shown an association with H. pylori, but not with bile reflux and inflammation [21,30]. In our study, the numbers of mononuclear cells and neutrophils decreased after gastrectomy in the spontaneous clearance group, suggesting suggests that the loss of H. pylori after gastrectomy is a major contributor to improvements in inflammation.

This study investigated whether the location of each remnant stomach (cardia, fundus, greater and lesser curvatures of the mid-body) impacted the spontaneous bacterial clearance rates; however, no differences were observed. We also evaluated histological factor differences at each location. All four factors (neutrophil and mononuclear cell numbers, atrophy, and intestinal metaplasia) showed significant improvement in the lesser curvatures of mid-bodies in the spontaneous clearance group, which is worthy of further study. Such studies might examine differences such as the degree of bile reflux among the locations.

This study has several limitations. It was conducted at a single center, involved a small number of patients, and had a relatively short follow-up period. Although atrophy and intestinal metaplasia tended to decrease over the postoperative follow-up period, a statistical significance was not observed, possibly because of the small number of patients and short follow-up period. Additionally, we could not assess postoperative antibiotic use. Although we could not investigate the impact of bile reflux differences because only patients undergoing B-I reconstruction were included, the high rate of spontaneous clearance suggests that there is a major cause other than bile reflux. Also, unlike other studies that included patients receiving adjuvant chemotherapy, we excluded such patients to control for the effect of chemotherapy on H. pylori clearance [19]. This study serves as a foundation for future large-scale studies. Furthermore, this study involved multiple comparisons of different histological factors, locations, and time points. Due to the exploratory nature of the study and the small sample size, we could not apply formal adjustments for multiple testing, such as Bonferroni correction. Therefore, the findings, especially those with marginal p-values, should be cautiously interpreted. Future studies involving larger sample sizes and statistical models that incorporate corrections for multiple testing are required to validate these preliminary observations.

In conclusion, we observed a high rate of spontaneous H. pylori clearance after subtotal gastrectomy (81.3%), with the highest incidence occurring within six postoperative months. This suggests that patient postoperative H. pylori status should be re-evaluated before starting eradication therapy.

Notes

Availability of Data and Material

The datasets generated or analyzed during the study are available from the corresponding author on reasonable request.

Conflicts of Interest

The authors have no financial conflicts of interest.

Funding Statement

This work was supported by IL-YANG Pharmaceutical Co., Ltd.

Acknowledgements

The authors thank Yang Soon Park for the histological examination and assessment.

Authors’ Contribution

Conceptualization: Ji Yong Ahn, Byung Sik Kim, So Young Byun, Hee Sung Kim. Data curation: all authors. Funding acquisition: Ji Yong Ahn. Investigation: all authors. Methodology: Ji Yong Ahn, Byung Sik Kim, So Young Byun, Hee Sung Kim. Project administration: Ji Yong Ahn, Byung Sik Kim, So Young Byun, Hee Sung Kim. Resources: So Young Byun, Hee Sung Kim. Software: So Young Byun, Hee Sung Kim. Supervision: Ji Yong Ahn. Validation: So Young Byun, Hee Sung Kim. Visualization: So Young Byun, Hee Sung Kim. Writing—original draft: So Young Byun. Writing—review & editing: So Young Byun. Approval of final manuscript: all authors.

Fig. 1.

Flowchart of H. pylori status. ESD, endoscopic submucosal dissection.

Table 1.

Baseline characteristics of patients according to postoperative Helicobacter pylori clearance

	Non-clearance (n=3)	Spontaneous clearance (n=13)	p-value
Age (yr)	48.7±12.1	58.4±7.7	0.239^*
Sex			>0.999^†
Male	2 (66.7)	8 (61.5)
Female	1 (33.3)	5 (38.5)
Smoking			0.131^‡
Never	0 (0)	7 (53.8)
Ex-smoker	1 (33.3)	2 (15.4)
Current	2 (66.7)	4 (30.8)
Alcohol			0.112^‡
Never	0 (0)	6 (46.2)
Ex-drinker	0 (0)	1 (7.7)
Current	3 (100)	6 (46.2)
Diagnosis			0.350^†
Early gastric cancer	2 (66.7)	12 (92.3)
Advanced gastric cancer	1 (33.3)	1 (7.7)
Cancer location			0.550^†
Antrum	2 (66.7)	5 (38.5)
Body	1 (33.3)	8 (61.5)
Surgical method			>0.999^†
Billroth I	3 (100)	13 (100)

Data are presented as mean±standard deviation or n (%).

^* Mann–Whitney test;

^† Fisher’s exact test;

^‡ Linear by linear association.

Table 2.

Rate of Helicobacter pylori spontaneous clearance according to postoperative period

	Value (n=16)
Spontaneous clearance of H. pylori	13 (81.3)
Postoperative period
Until 6 months	8 (50.0)
Between 6 and 12 months	5 (31.3)

Table 3.

Neutrophil counts in patient groups

Location	Non-clearance (n=3)	p-value^†	Spontaneous clearance (n=13)	p-value^†	p-value^‡
Cardia
Baseline	2.33±0.57		1.61±0.86		0.239
Post 6 months	1.66±0.57	0.157	1.07±0.49	0.053	0.189
Post 12 months	1.33±1.15	0.180	0.84±0.55	0.021^*	0.364
Fundus
Baseline	1.33±0.57		1.38±0.65		>0.999
Post 6 months	1.66±0.57	0.317	1.46±0.51	0.739	0.611
Post 12 months	0.66±0.57	0.317	0.84±0.68	0.053	0.800
Greater curvature of mid body
Baseline	2.00±0.00		1.61±0.76		0.364
Post 6 months	1.66±0.57	0.317	1.30±0.75	0.206	0.439
Post 12 months	1.33±1.52	0.414	1.23±0.92	0.327	>0.999
Lesser curvature of mid body
Baseline	2.33±0.57		1.76±0.72		0.296
Post 6 months	2.00±0.00	0.317	1.23±0.72	0.038^*	0.082
Post 12 months	1.66±1.52	0.414	0.92±0.49	0.004^*	0.364

Data are presented as mean±standard deviation.

^* p<0.05;

^† Change from baseline, Wilcoxon signed-rank test;

^‡ Comparison between the non-clearance and spontaneous clearance group, Mann–Whitney U-test.

Table 4.

Mononuclear cell counts in patient groups

Location	Non-clearance (n=3)	p-value^†	Spontaneous clearance (n=13)	p-value^†	p-value^‡
Cardia
Baseline	2.00±1.00		2.00±0.70		>0.999
Post 6 months	2.33±0.57	0.317	1.46±0.51	0.020^*	0.082
Post 12 months	1.33±1.52	0.593	1.23±0.72	0.014^*	>0.999
Fundus
Baseline	1.33±0.57		1.53±0.51		0.611
Post 6 months	2.00±1.00	0.157	1.46±0.77	0.739	0.364
Post 12 months	1.00±1.00	0.655	1.23±0.72	0.206	0.800
Greater curvature of mid body
Baseline	1.66±0.57		1.84±0.80		0.800
Post 6 months	2.33±0.57	0.157	1.53±0.87	0.206	0.146
Post 12 months	1.33±1.15	0.655	1.15±0.80	0.056	0.704
Lesser curvature of mid body
Baseline	2.66±0.57		2.38±0.65		0.900
Post 6 months	2.33±0.57	>0.999	1.69±0.85	0.030^*	0.239
Post 12 months	1.33±1.52	0.414	1.38±0.96	0.016^*	0.900

Data are presented as mean±standard deviation.

^* p<0.05;

^† Change from baseline, Wilcoxon signed-rank test;

^‡ Comparison between the non-clearance and spontaneous clearance groups, Mann–Whitney U-test.

Table 5.

Stomach atrophy in patient groups

Location	Non-clearance (n=3)	p-value^†	Spontaneous clearance (n=13)	p-value^†	p-value^‡
Atrophy (cardia)
Baseline	1.66±1.52		1.30±1.10		0.704
Post 6 months	1.00±1.00	0.157	1.30±0.63	>0.999	0.611
Post 12 months	0.66±0.57	0.414	0.92±0.64	0.346	0.611
Atrophy (fundus)
Baseline	0.33±0.57		0.69±0.63		0.439
Post 6 months	1.00±1.00	0.157	0.92±0.64	0.257	0.900
Post 12 months	0.00±0.00	0.317	0.53±0.66	0.414	0.239
Atrophy (greater curvature of mid body)
Baseline	0.00±0.00		0.30±0.48		0.439
Post 6 months	0.33±0.57	0.317	0.76±0.43	0.014^*	0.296
Post 12 months	0.00±0.00	>0.999	0.46±0.66	0.480	0.364
Atrophy (lesser curvature of mid body)
Baseline	1.33±0.57		1.07±0.64		0.611
Post 6 months	1.00±1.00	0.317	0.76±0.72	0.279	0.704
Post 12 months	0.66±0.57	0.317	0.46±0.51	0.033^*	0.611

Data are presented as mean±standard deviation.

^* p<0.05;

^† Change from baseline, Wilcoxon signed-rank test;

^‡ Comparison between the non-clearance and spontaneous clearance groups, Mann–Whitney U-test.

Table 6.

Intestinal metaplasia in patient groups

Location	Non-clearance (n=3)	p-value^†	Spontaneous clearance (n=13)	p-value^†	p-value^‡
Cardia
Baseline	1.33±1.15		1.15±1.14		0.800
Post 6 months	1.00±1.00	0.317	1.00±1.08	0.566	0.900
Post 12 months	0.00±0.00	0.157	0.61±0.96	0.083	0.364
Fundus
Baseline	0.00±0.00		0.07±0.27		0.900
Post 6 months	0.00±0.00	>0.999	0.30±0.85	0.414	0.704
Post 12 months	0.00±0.00	>0.999	0.00±0.00	0.317	>0.999
Greater curvature of mid body
Baseline	0.00±0.00		0.00±0.00		>0.999
Post 6 months	0.00±0.00	>0.999	0.00±0.00	>0.999	>0.999
Post 12 months	0.00±0.00	>0.999	0.00±0.00	>0.999	>0.999
Lesser curvature of mid body
Baseline	1.66±0.57		1.23±1.23		0.521
Post 6 months	0.00±0.00	0.102	0.61±1.19	0.170	0.611
Post 12 months	0.33±0.57	0.157	0.38±0.86	0.026^*	0.900

Data are presented as mean±standard deviation.

^* p<0.05;

^† Change from baseline, Wilcoxon signed-rank test;

^‡ Comparison between the non-clearance and spontaneous clearance groups, Mann–Whitney U-test.

Table 7.

Rate of Helicobacter pylori clearance according to location

	Cardia (n=16)	Fundus (n=16)	Greater curvature of mid body (n=16)	Lesser curvature of mid body (n=16)	p-value^*
Baseline H. pylori positive	13 (81.2)	13 (81.2)	13 (81.2)	12 (75.0)	0.679
Spontaneous clearance (after 6 months)	9/13 (69.2)	6/13 (46.1)	5/13 (38.4)	5/12 (41.6)	0.149

Data are presented as n (%).

^* Linear-by-linear association.

REFERENCES

1. Kato M, Asaka M, Shimizu Y, Nobuta A, Takeda H, Sugiyama T.; Multi-Centre Study Group. Relationship between Helicobacter pylori infection and the prevalence, site and histological type of gastric cancer. Aliment Pharmacol Ther 2004;20(Suppl 1): 85–89.

2. Sekiguchi M, Oda I, Matsuda T, Saito Y. Epidemiological trends and future perspectives of gastric cancer in Eastern Asia. Digestion 2022;103:22–28.

3. Shin WS, Xie F, Chen B, et al. Updated epidemiology of gastric cancer in Asia: decreased incidence but still a big challenge. Cancers (Basel) 2023;15:2639.

4. Karimi P, Islami F, Anandasabapathy S, Freedman ND, Kamangar F. Gastric cancer: descriptive epidemiology, risk factors, screening, and prevention. Cancer Epidemiol Biomarkers Prev 2014;23:700–713.

5. Forman D. Helicobacter pylori and gastric cancer. Scand J Gastroenterol Suppl 1996;214:31–33; discussion 40-43.

6. The EUROGAST Study Group. An international association between Helicobacter pylori infection and gastric cancer. Lancet 1993;341:1359–1362.

7. Kuipers EJ. Relationship between Helicobacter pylori, atrophic gastritis and gastric cancer. Aliment Pharmacol Ther 1998;12(Suppl 1): 25–36.

8. Genta RM. Helicobacter pylori as a promoter of intestinal metaplasia and gastric cancer: an alluring hypothesis in search of evidence. Eur J Gastroenterol Hepatol 1995;7(Suppl 1): S25–S30.

9. Ohkusa T, Fujiki K, Takashimizu I, et al. Improvement in atrophic gastritis and intestinal metaplasia in patients in whom Helicobacter pylori was eradicated. Ann Intern Med 2001;134:380–386.

10. Ito M, Haruma K, Kamada T, et al. Helicobacter pylori eradication therapy improves atrophic gastritis and intestinal metaplasia: a 5-year prospective study of patients with atrophic gastritis. Aliment Pharmacol Ther 2002;16:1449–1456.

11. Liou JM, Malfertheiner P, Lee YC, et al. Screening and eradication of Helicobacter pylori for gastric cancer prevention: the Taipei global consensus. Gut 2020;69:2093–2112.

12. Lansdorp-Vogelaar I, Sharp L. Cost-effectiveness of screening and treating Helicobacter pylori for gastric cancer prevention. Best Pract Res Clin Gastroenterol 2013;27:933–947.

13. Malfertheiner P, Sipponen P, Naumann M, et al. Helicobacter pylori eradication has the potential to prevent gastric cancer: a state-of-the-art critique. Am J Gastroenterol 2005;100:2100–2115.

14. Argueta EA, Moss SF. The prevention of gastric cancer by Helicobacter pylori eradication. Curr Opin Gastroenterol 2021;37:625–630.

15. Lin YS, Chen MJ, Shih SC, Bair MJ, Fang CJ, Wang HY. Management of Helicobacter pylori infection after gastric surgery. World J Gastroenterol 2014;20:5274–5282.

16. Kato T, Motoyama H, Akiyama N. [Helicobacter pylori infection in gastric remnant cancer after gastrectomy]. Nihon Rinsho 2003;61:30–35; Japanese.

17. Kawai Y, Tazuma S, Inoue M. Bile acid reflux and possible inhibition of Helicobacter pylori infection in subjects without gastric surgery. Dig Dis Sci 2001;46:1779–1783.

18. Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis: the updated Sydney system. Am J Surg Pathol 1996;20:1161–1181.

19. Yoon K, Kim N, Kim J, et al. Dynamic changes in Helicobacter pylori status following gastric cancer surgery. Gut Liver 2017;11:209–215.

20. Bair MJ, Wu MS, Chang WH, et al. Spontaneous clearance of Helicobacter pylori colonization in patients with partial gastrectomy: correlates with operative procedures and duration after operation. J Formos Med Assoc 2009;108:13–19.

21. Li XB, Lu H, Chen HM, Chen XY, Ge ZZ. Role of bile reflux and Helicobacter pylori infection on inflammation of gastric remnant after distal gastrectomy. J Dig Dis 2008;9:208–212.

22. Tomtitchong P, Onda M, Matsukura N, et al. Helicobacter pylori infection in the remnant stomach after gastrectomy: with special reference to the difference between Billroth I and II anastomoses. J Clin Gastroenterol 1998;27(Suppl 1):S154–S158.

23. Ritchie WP. Alkaline reflux gastritis: a critical reappraisal. Gut 1984;25:975–987.

24. Nagahata Y, Kawakita N, Azumi Y, Numata N, Yano M, Saitoh Y. Etiological involvement of Helicobacter pylori in “reflux” gastritis after gastrectomy. Am J Gastroenterol 1996;91:2130–2134.

25. Abe H, Murakami K, Satoh S, et al. Influence of bile reflux and Helicobacter pylori infection on gastritis in the remnant gastric mucosa after distal gastrectomy. J Gastroenterol 2005;40:563–569.

26. Leivonen M, Nordling S, Haglund C. Does Helicobacter pylori in the gastric stump increase the cancer risk after certain reconstruction types? Anticancer Res 1997;17:3893–3896.

27. Fournier BM, Parkos CA. The role of neutrophils during intestinal inflammation. Mucosal Immunol 2012;5:354–366.

28. Nomura S, Terao S, Adachi K, et al. Endoscopic diagnosis of gastric mucosal activity and inflammation. Dig Endosc 2013;25:136–146.

29. Farah R, Khamisy-Farah R. Association of neutrophil to lymphocyte ratio with presence and severity of gastritis due to Helicobacter pylori infection. J Clin Lab Anal 2014;28:219–223.

30. Lee Y, Tokunaga A, Tajiri T, et al. Inflammation of the gastric remnant after gastrectomy: mucosal erythema is associated with bile reflux and inflammatory cellular infiltration is associated with Helicobacter pylori infection. J Gastroenterol 2004;39:520–526.